Report overview
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cells. This report contains market size and forecasts of Mesenchymal Stem Cells in global, including the following market information:
Global Mesenchymal Stem Cells Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Mesenchymal Stem Cells market was valued at US$ 213.1 million in 2022 and is projected to reach US$ 286.3 million by 2029, at a CAGR of 4.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The top 3 manufacturters of Mesenchymal Stem Cells include ?Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.
North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.
We surveyed the Mesenchymal Stem Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mesenchymal Stem Cells Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Mesenchymal Stem Cells Market Segment Percentages, by Type, 2022 (%)
Human MSC
Mouse MSC
Rat MSC
Others
Global Mesenchymal Stem Cells Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Mesenchymal Stem Cells Market Segment Percentages, by Application, 2022 (%)
Research Institute
Hospital
Others
Global Mesenchymal Stem Cells Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Mesenchymal Stem Cells Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mesenchymal Stem Cells revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Mesenchymal Stem Cells revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell GmbH
Genlantis
Celprogen
Cell Applications
Cyagen Biosciences
Axol Bioscience
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mesenchymal Stem Cells, market overview.
Chapter 2: Global Mesenchymal Stem Cells market size in revenue.
Chapter 3: Detailed analysis of Mesenchymal Stem Cells company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mesenchymal Stem Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
